Letermovir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 7 USDMF, 1 EU WC, 3 KDMF, 1 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

16 Intermediate Suppliers

16 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers, 8 FDA Orange Book, 14 Europe, 3 Canada, 2 South Africa

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 2 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 13 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 8 Co-Processed Excipients, 7 Coating Systems & Additives, 6 Parenteral, 5 Taste Masking, 4 Film Formers & Plasticizers, 3 Solubilizers, 3 Controlled & Modified Release, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 API Stability Enhancers, 2 Coloring Agents, 2 Rheology Modifiers

DIGITAL CONTENT

18 News #PharmaBuzz

18 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 32 US Exclusivities, 4 Health Canada Patents

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Zydus Lifesciences launches ANVIMO

06 Mar 2025

// INDPHARMAPOST

AiCuris Achieves Milestones In Anti-viral Solutions For At-Risk Patients

17 Jul 2024

// BUSINESSWIRE

Health Canada approves new indication for Merck’s Prevymis

22 Apr 2024

// PHARMABIZ

Merck Receives Positive EU CHMP Opinion for PREVYMIS

17 Oct 2023

// BUSINESSWIRE

Merck's CMV drug is approved for kidney transplant patients

07 Jun 2023

// Katherine Lewin ENDPTS

U.S. FDA Approves New Indication for Merck’s PREVYMIS for Prevention of CMV

06 Jun 2023

// BUSINESSWIRE

Letermovir

Letermovir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers

7 USDMF

1 EU WC

3 KDMF

1 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

20 Drugs in Development

INTERMEDIATES

16 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers

8 FDA Orange Book

14 Europe

3 Canada

2 South Africa

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

3 DKSH

5 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Kirsch Pharma

2 Actylis

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

5 DFE Pharma

5 Gangwal Chemicals

1 Ideal Cures

1 Ingredion Pharma Solutions

10 Kerry

2 Keval Exports

9 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

14 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders

13 Disintegrants & Superdisintegrants

13 Granulation

13 Direct Compression

11 Thickeners and Stabilizers

10 Lubricants & Glidants

8 Co-Processed Excipients

7 Coating Systems & Additives

6 Parenteral

5 Taste Masking

4 Film Formers & Plasticizers

3 Solubilizers

3 Controlled & Modified Release

3 Emulsifying Agents

3 Chewable & Orodispersible Aids

2 API Stability Enhancers

2 Coloring Agents

2 Rheology Modifiers

DIGITAL CONTENT

18 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

5 Annual Reports

MARKET PLACE

2 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents

32 US Exclusivities

4 Health Canada Patents